| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-09-11 00:30:30 UTC |
|---|
| Update Date | 2021-09-26 22:57:14 UTC |
|---|
| HMDB ID | HMDB0247503 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | 6-Methyl-N-(2H-tetrazol-5-yl)pyridine-2-carboxamide |
|---|
| Description | 6-Methyl-N-(2H-tetrazol-5-yl)pyridine-2-carboxamide belongs to the class of organic compounds known as pyridinecarboxamides. Pyridinecarboxamides are compounds containing a pyridine ring bearing a carboxamide. Based on a literature review very few articles have been published on 6-Methyl-N-(2H-tetrazol-5-yl)pyridine-2-carboxamide. This compound has been identified in human blood as reported by (PMID: 31557052 ). 6-methyl-n-(2h-tetrazol-5-yl)pyridine-2-carboxamide is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically 6-Methyl-N-(2H-tetrazol-5-yl)pyridine-2-carboxamide is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | CC1=CC=CC(=N1)C(=O)NC1=NNN=N1 InChI=1S/C8H8N6O/c1-5-3-2-4-6(9-5)7(15)10-8-11-13-14-12-8/h2-4H,1H3,(H2,10,11,12,13,14,15) |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C8H8N6O |
|---|
| Average Molecular Weight | 204.193 |
|---|
| Monoisotopic Molecular Weight | 204.075958902 |
|---|
| IUPAC Name | 6-methyl-N-(2H-1,2,3,4-tetrazol-5-yl)pyridine-2-carboxamide |
|---|
| Traditional Name | 6-methyl-N-(2H-1,2,3,4-tetrazol-5-yl)pyridine-2-carboxamide |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC1=CC=CC(=N1)C(=O)NC1=NNN=N1 |
|---|
| InChI Identifier | InChI=1S/C8H8N6O/c1-5-3-2-4-6(9-5)7(15)10-8-11-13-14-12-8/h2-4H,1H3,(H2,10,11,12,13,14,15) |
|---|
| InChI Key | UQHAIRDRZJDIBZ-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as pyridinecarboxamides. Pyridinecarboxamides are compounds containing a pyridine ring bearing a carboxamide. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Pyridines and derivatives |
|---|
| Sub Class | Pyridinecarboxylic acids and derivatives |
|---|
| Direct Parent | Pyridinecarboxamides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Pyridinecarboxamide
- 2-heteroaryl carboxamide
- Methylpyridine
- Azole
- Tetrazole
- Heteroaromatic compound
- Carboxamide group
- Secondary carboxylic acid amide
- Azacycle
- Carboxylic acid derivative
- Organic nitrogen compound
- Organooxygen compound
- Organonitrogen compound
- Hydrocarbon derivative
- Organic oxygen compound
- Organic oxide
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Predicted by Siyang on May 30, 2022 | 10.1865 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 3.01 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1441.7 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 314.5 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 102.0 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 182.0 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 76.3 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 308.4 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 384.4 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 111.3 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 760.2 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 256.0 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1051.0 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 236.5 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 272.3 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 437.4 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 245.0 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 229.4 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 6-Methyl-N-(2H-tetrazol-5-yl)pyridine-2-carboxamide,1TMS,isomer #1 | CC1=CC=CC(C(=O)N(C2=N[NH]N=N2)[Si](C)(C)C)=N1 | 1950.1 | Semi standard non polar | 33892256 | | 6-Methyl-N-(2H-tetrazol-5-yl)pyridine-2-carboxamide,1TMS,isomer #1 | CC1=CC=CC(C(=O)N(C2=N[NH]N=N2)[Si](C)(C)C)=N1 | 2024.8 | Standard non polar | 33892256 | | 6-Methyl-N-(2H-tetrazol-5-yl)pyridine-2-carboxamide,1TMS,isomer #1 | CC1=CC=CC(C(=O)N(C2=N[NH]N=N2)[Si](C)(C)C)=N1 | 3540.3 | Standard polar | 33892256 | | 6-Methyl-N-(2H-tetrazol-5-yl)pyridine-2-carboxamide,1TMS,isomer #2 | CC1=CC=CC(C(=O)NC2=NN([Si](C)(C)C)N=N2)=N1 | 2180.1 | Semi standard non polar | 33892256 | | 6-Methyl-N-(2H-tetrazol-5-yl)pyridine-2-carboxamide,1TMS,isomer #2 | CC1=CC=CC(C(=O)NC2=NN([Si](C)(C)C)N=N2)=N1 | 2035.8 | Standard non polar | 33892256 | | 6-Methyl-N-(2H-tetrazol-5-yl)pyridine-2-carboxamide,1TMS,isomer #2 | CC1=CC=CC(C(=O)NC2=NN([Si](C)(C)C)N=N2)=N1 | 3788.0 | Standard polar | 33892256 | | 6-Methyl-N-(2H-tetrazol-5-yl)pyridine-2-carboxamide,2TMS,isomer #1 | CC1=CC=CC(C(=O)N(C2=NN([Si](C)(C)C)N=N2)[Si](C)(C)C)=N1 | 2088.1 | Semi standard non polar | 33892256 | | 6-Methyl-N-(2H-tetrazol-5-yl)pyridine-2-carboxamide,2TMS,isomer #1 | CC1=CC=CC(C(=O)N(C2=NN([Si](C)(C)C)N=N2)[Si](C)(C)C)=N1 | 2025.0 | Standard non polar | 33892256 | | 6-Methyl-N-(2H-tetrazol-5-yl)pyridine-2-carboxamide,2TMS,isomer #1 | CC1=CC=CC(C(=O)N(C2=NN([Si](C)(C)C)N=N2)[Si](C)(C)C)=N1 | 3102.8 | Standard polar | 33892256 | | 6-Methyl-N-(2H-tetrazol-5-yl)pyridine-2-carboxamide,1TBDMS,isomer #1 | CC1=CC=CC(C(=O)N(C2=N[NH]N=N2)[Si](C)(C)C(C)(C)C)=N1 | 2174.0 | Semi standard non polar | 33892256 | | 6-Methyl-N-(2H-tetrazol-5-yl)pyridine-2-carboxamide,1TBDMS,isomer #1 | CC1=CC=CC(C(=O)N(C2=N[NH]N=N2)[Si](C)(C)C(C)(C)C)=N1 | 2148.1 | Standard non polar | 33892256 | | 6-Methyl-N-(2H-tetrazol-5-yl)pyridine-2-carboxamide,1TBDMS,isomer #1 | CC1=CC=CC(C(=O)N(C2=N[NH]N=N2)[Si](C)(C)C(C)(C)C)=N1 | 3567.3 | Standard polar | 33892256 | | 6-Methyl-N-(2H-tetrazol-5-yl)pyridine-2-carboxamide,1TBDMS,isomer #2 | CC1=CC=CC(C(=O)NC2=NN([Si](C)(C)C(C)(C)C)N=N2)=N1 | 2355.1 | Semi standard non polar | 33892256 | | 6-Methyl-N-(2H-tetrazol-5-yl)pyridine-2-carboxamide,1TBDMS,isomer #2 | CC1=CC=CC(C(=O)NC2=NN([Si](C)(C)C(C)(C)C)N=N2)=N1 | 2234.1 | Standard non polar | 33892256 | | 6-Methyl-N-(2H-tetrazol-5-yl)pyridine-2-carboxamide,1TBDMS,isomer #2 | CC1=CC=CC(C(=O)NC2=NN([Si](C)(C)C(C)(C)C)N=N2)=N1 | 3750.8 | Standard polar | 33892256 | | 6-Methyl-N-(2H-tetrazol-5-yl)pyridine-2-carboxamide,2TBDMS,isomer #1 | CC1=CC=CC(C(=O)N(C2=NN([Si](C)(C)C(C)(C)C)N=N2)[Si](C)(C)C(C)(C)C)=N1 | 2488.1 | Semi standard non polar | 33892256 | | 6-Methyl-N-(2H-tetrazol-5-yl)pyridine-2-carboxamide,2TBDMS,isomer #1 | CC1=CC=CC(C(=O)N(C2=NN([Si](C)(C)C(C)(C)C)N=N2)[Si](C)(C)C(C)(C)C)=N1 | 2393.7 | Standard non polar | 33892256 | | 6-Methyl-N-(2H-tetrazol-5-yl)pyridine-2-carboxamide,2TBDMS,isomer #1 | CC1=CC=CC(C(=O)N(C2=NN([Si](C)(C)C(C)(C)C)N=N2)[Si](C)(C)C(C)(C)C)=N1 | 3106.9 | Standard polar | 33892256 |
|
|---|